Physician and Patient Preferences for the Treatment of Metastatic Castration-Sensitive and Castration-Resistant Prostate Cancer: A Best-Worst Scaling Study in Japan.

ABSTRACT:

Introduction

Despite many prostate cancer (PC) treatment options in Japan, physicians' and patients' preferences in metastatic castration-sensitive PC (mCSPC) and castration-resistant PC (CRPC) are unclear.

Methods

For this cross-sectional study, an online questionnaire survey based on the best-worst scaling (profile case) approach was designed. Physicians' and patients' questionnaires, comprising six attributes (efficacy, safety, target patients, dosage, administration, and medical expenditures), had 24 and 26 items for mCSPC and CRPC surveys, respectively. Four items were presented during each session; respondents selected the "most important" and "least important" among these. The objective was to elicit attributes important for treatment and their relative importance lev

SUBMITTER: Kimura T 

PROVIDER: S-EPMC11880441 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature